SCHEMBL6563150

SCHEMBL6563150

CC(C)(C)[SiH2]OC(C)(C)c1ccc(OCc2cc(C=O)cs2)cc1C(C)(C)O[SiH2]C(C)(C)C

nearest known ligand 0.32

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
MAOA P21397 2/20 0.30
MAOB P27338 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6563890 0.84 MGMT (0.31)
SCHEMBL6564971 0.80
SCHEMBL6562773 0.77
SCHEMBL6566273 0.74
SCHEMBL6564649 0.74
SCHEMBL6564525 0.73 VDR (0.41)
SCHEMBL6562933 0.71 MRGPRX4 (0.32)
SCHEMBL6564820 0.70
SCHEMBL6563146 0.70 BACE1 (0.33) NPC1RAB9ATDP1MAOAMAOB
SCHEMBL6566426 0.70 FFAR1 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1235824-B1 VITAMIN D ANALOGUES GALDERMA RES & DEV (FR) 2004-05-19 EP disclosed
EP-1235824-A1 VITAMIN D ANALOGUES Galderma Research & Development, S.N.C. (FR) 2002-09-04 EP disclosed
WO-2001038320-A1 VITAMIN D ANALOGUES GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) 2001-05-31 WO disclosed